Excellio Labs

Excellio Labs is a biotech developing engineered exosome platforms for targeted drug delivery.

The technology exploits the inherent tissue-specificity of iPSC-derived extracellular vesicles, which are further surface-modified to create precision drug carriers capable of delivering nucleic acids, proteins, and small molecules to previously unaddressed therapeutic targets.

Exosome delivery systems are offered to pharmaceutical partners developing advanced biological therapies, with priority applications in oncology and neurodegeneration.